Yue Wei, PhD, discusses how TET2 mutations influence platelet response and prognosis in patients with MDS receiving hypomethylating agents.
Yue Wei, PhD
Advertisement
Yue Wei, PhD, is an assistant professor in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center in Houston.
Articles by Yue Wei, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
The Role of Elacestrant in ER+/HER2– Advanced Breast Cancer Harboring ESR1 Mutations
2
Nemtabrutinib With Venetoclax Shows Promising Activity in R/R CLL/SLL
3
Maintenance Gemogenovatucel-T Shows Survival Benefit in cTMB-High/HRP Ovarian Cancer
4
Pembrolizumab Fails to Yield Responses in Recurrent Medullary Thyroid Cancer
5